Lei Yan

3.8k total citations · 1 hit paper
62 papers, 2.1k citations indexed

About

Lei Yan is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lei Yan has authored 62 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Epidemiology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lei Yan's work include Intracranial Aneurysms: Treatment and Complications (9 papers), TGF-β signaling in diseases (9 papers) and Hepatitis B Virus Studies (8 papers). Lei Yan is often cited by papers focused on Intracranial Aneurysms: Treatment and Complications (9 papers), TGF-β signaling in diseases (9 papers) and Hepatitis B Virus Studies (8 papers). Lei Yan collaborates with scholars based in China, United States and Australia. Lei Yan's co-authors include Rex C. Haydon, Hue H. Luu, Chengfu Yuan, Wenping Luo, Guosheng Ren, Bo Huang, Yixiao Feng, Linghuan Zhang, Xiaojuan Ji and Shifeng Huang and has published in prestigious journals such as Biochemistry, Cancer Research and Stroke.

In The Last Decade

Lei Yan

60 papers receiving 2.1k citations

Hit Papers

Breast cancer development and progression: Risk factors, ... 2018 2026 2020 2023 2018 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
    2018 936 citations Yixiao Feng, Shifeng Huang et al. Genes & Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lei Yan China 17 1.0k 639 357 251 166 62 2.1k
Cristina Sánchez‐de‐Diego Spain 14 842 0.8× 523 0.8× 379 1.1× 218 0.9× 76 0.5× 26 1.8k
Robert A. Parise United States 30 1.4k 1.3× 1.0k 1.6× 169 0.5× 248 1.0× 172 1.0× 100 3.0k
Vijay Pandey China 30 1.4k 1.4× 658 1.0× 706 2.0× 226 0.9× 276 1.7× 105 2.5k
Hwa‐Chain Robert Wang United States 28 1.5k 1.5× 507 0.8× 297 0.8× 268 1.1× 72 0.4× 72 2.4k
Ovidiu Bălăcescu Romania 21 1.4k 1.3× 718 1.1× 644 1.8× 268 1.1× 83 0.5× 113 2.4k
Wolfram C. M. Dempke Germany 20 727 0.7× 727 1.1× 258 0.7× 397 1.6× 109 0.7× 48 1.8k
Cindy H. Chau United States 28 1.1k 1.1× 808 1.3× 473 1.3× 540 2.2× 102 0.6× 73 2.8k
Yingjie Yu United States 31 2.0k 1.9× 946 1.5× 720 2.0× 170 0.7× 115 0.7× 63 3.2k
Hemant K. Bid India 33 1.2k 1.2× 574 0.9× 422 1.2× 383 1.5× 268 1.6× 72 2.5k
Mayank Singh India 23 1.4k 1.4× 682 1.1× 595 1.7× 314 1.3× 70 0.4× 66 2.5k

Countries citing papers authored by Lei Yan

Since Specialization
Citations

This map shows the geographic impact of Lei Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Yan more than expected).

Fields of papers citing papers by Lei Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Yan. The network helps show where Lei Yan may publish in the future.

Co-authorship network of co-authors of Lei Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Yan. A scholar is included among the top collaborators of Lei Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Yan. Lei Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Zhouyu, Wei Le, Lei Yan, et al.. (2023). Case Report: Response to crizotinib treatment in a patient with advanced non-small cell lung cancer with LDLR-ROS1 fusion. Frontiers in Oncology. 13. 1169876–1169876. 1 indexed citations
3.
4.
5.
Zhao, Qingqing, Kehui Liu, Xiaojun Zhu, et al.. (2020). Anti-viral effect in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase. Antiviral Research. 184. 104953–104953. 8 indexed citations
6.
Zheng, Yan, Yuan Ma, Huixia Cao, et al.. (2020). Identification of fenoldopam as a novel LSD1 inhibitor to abrogate the proliferation of renal cell carcinoma using drug repurposing strategy. Bioorganic Chemistry. 108. 104561–104561. 9 indexed citations
7.
Liu, Ping, Nana Chen, Lei Yan, et al.. (2019). Preparation, characterisation and in vitro and in vivo evaluation of CD44-targeted chondroitin sulphate-conjugated doxorubicin PLGA nanoparticles. Carbohydrate Polymers. 213. 17–26. 52 indexed citations
8.
Feng, Yixiao, Shifeng Huang, Chengfu Yuan, et al.. (2018). Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes & Diseases. 5(2). 77–106. 936 indexed citations breakdown →
9.
Yan, Lei, Chuanwu Zhu, Jing Li, et al.. (2018). Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients. Infection and Drug Resistance. Volume 11. 2001–2009. 12 indexed citations
10.
Yan, Lei, Fangfang Lai, Xiaoguang Chen, et al.. (2017). Design, synthesis and biological evaluation of novel indolin-2-ones as potent anticancer compounds. Bioorganic & Medicinal Chemistry Letters. 27(15). 3326–3331. 16 indexed citations
11.
Yan, Lei, Fangfang Lai, Xiaoguang Chen, & Zhiyan Xiao. (2015). Discovery of novel indirubin-3′-monoxime derivatives as potent inhibitors against CDK2 and CDK9. Bioorganic & Medicinal Chemistry Letters. 25(11). 2447–2451. 29 indexed citations
12.
13.
Shi, Wanyin, et al.. (2014). Application of dual Willis covered stents in the management of large fusiform carotid aneurysms in a canine model. Vascular. 22(6). 432–438. 11 indexed citations
14.
Wu, Wenjuan, Bi Chen, Kelly M. Credille, et al.. (2013). Inhibition of Tumor Growth and Metastasis in Non–Small Cell Lung Cancer by LY2801653, an Inhibitor of Several Oncokinases, Including MET. Clinical Cancer Research. 19(20). 5699–5710. 53 indexed citations
15.
Wang, Dan, Guobin Zhang, Lei Yan, et al.. (2012). CT and enhanced CT in diagnosis of gastrointestinal neuroendocrine carcinomas. Abdominal Radiology. 37(5). 738–745. 14 indexed citations
16.
Chen, Yuefeng, Tao Wei, Lei Yan, et al.. (2008). Developing and applying a gene functional association network for anti-angiogenic kinase inhibitor activity assessment in an angiogenesis co-culture model. BMC Genomics. 9(1). 264–264. 17 indexed citations
17.
Farrington, Daphne L., Jonathan M. Yingling, Lei Yan, et al.. (2007). Development and validation of a phosphorylated SMADex vivostimulation assay. Biomarkers. 12(3). 313–330. 17 indexed citations
18.
Yingling, Jonathan M., Jianyong Shou, Xiaoling Xia, et al.. (2006). A small molecule inhibitor of TGFβ RI kinase potentiates VEGF dependent angiogenesis in vitro. Cancer Research. 66. 59–59. 1 indexed citations
19.
Sawyer, J. Scott, Douglas W. Beight, Bryan D. Anderson, et al.. (2004). Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-β type I receptor kinase domain. Bioorganic & Medicinal Chemistry Letters. 14(13). 3581–3584. 141 indexed citations
20.
Li, Baolin, Su Yuan, John Ryder, et al.. (2003). RIFLE: A novel ring zinc finger‐leucine‐rich repeat containing protein, regulates select cell adhesion molecules in PC12 cells. Journal of Cellular Biochemistry. 90(6). 1224–1241. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Sánchez‐de‐Diego Breakdown of academic impact, for papers by Robert A. Parise Breakdown of academic impact, for papers by Vijay Pandey Breakdown of academic impact, for papers by Hwa‐Chain Robert Wang Breakdown of academic impact, for papers by Ovidiu Bălăcescu Breakdown of academic impact, for papers by Wolfram C. M. Dempke Breakdown of academic impact, for papers by Cindy H. Chau Breakdown of academic impact, for papers by Yingjie Yu Breakdown of academic impact, for papers by Hemant K. Bid Breakdown of academic impact, for papers by Mayank Singh
Rankless by CCL
2026